182 related articles for article (PubMed ID: 30209894)
1. PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis.
Rawcliffe DFR; Österman L; Nordin A; Holmberg M
Mol Genet Genomic Med; 2018 Nov; 6(6):887-897. PubMed ID: 30209894
[TBL] [Abstract][Full Text] [Related]
2. The defective splicing caused by the ISCU intron mutation in patients with myopathy with lactic acidosis is repressed by PTBP1 but can be derepressed by IGF2BP1.
Nordin A; Larsson E; Holmberg M
Hum Mutat; 2012 Mar; 33(3):467-70. PubMed ID: 22125086
[TBL] [Abstract][Full Text] [Related]
3. The High Level of Aberrant Splicing of ISCU in Slow-Twitch Muscle May Involve the Splicing Factor SRSF3.
Rawcliffe DF; Österman L; Lindsten H; Holmberg M
PLoS One; 2016; 11(10):e0165453. PubMed ID: 27783661
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific splicing of ISCU results in a skeletal muscle phenotype in myopathy with lactic acidosis, while complete loss of ISCU results in early embryonic death in mice.
Nordin A; Larsson E; Thornell LE; Holmberg M
Hum Genet; 2011 Apr; 129(4):371-8. PubMed ID: 21165651
[TBL] [Abstract][Full Text] [Related]
5. Myopathy with lactic acidosis is linked to chromosome 12q23.3-24.11 and caused by an intron mutation in the ISCU gene resulting in a splicing defect.
Olsson A; Lind L; Thornell LE; Holmberg M
Hum Mol Genet; 2008 Jun; 17(11):1666-72. PubMed ID: 18296749
[TBL] [Abstract][Full Text] [Related]
6. Tissue specificity of a human mitochondrial disease: differentiation-enhanced mis-splicing of the Fe-S scaffold gene ISCU renders patient cells more sensitive to oxidative stress in ISCU myopathy.
Crooks DR; Jeong SY; Tong WH; Ghosh MC; Olivierre H; Haller RG; Rouault TA
J Biol Chem; 2012 Nov; 287(48):40119-30. PubMed ID: 23035118
[TBL] [Abstract][Full Text] [Related]
7. Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy.
Sanaker PS; Toompuu M; Hogan VE; He L; Tzoulis C; Chrzanowska-Lightowlers ZM; Taylor RW; Bindoff LA
Biochim Biophys Acta; 2010 Jun; 1802(6):539-44. PubMed ID: 20206689
[TBL] [Abstract][Full Text] [Related]
8. Use of antisense oligonucleotides to correct the splicing error in ISCU myopathy patient cell lines.
Holmes-Hampton GP; Crooks DR; Haller RG; Guo S; Freier SM; Monia BP; Rouault TA
Hum Mol Genet; 2016 Dec; 25(23):5178-5187. PubMed ID: 28007899
[TBL] [Abstract][Full Text] [Related]
9. Skipping of exon 10 in
Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
[TBL] [Abstract][Full Text] [Related]
10. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Exon 8/8a Splicing by Downregulated PTBP (Polypyrimidine Tract-Binding Protein) 1 Increases Ca
Lei J; Liu X; Song M; Zhou Y; Fan J; Shen X; Xu X; Kapoor I; Zhu G; Wang (王觉进) J
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2440-2453. PubMed ID: 32787518
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotide corrects splice abnormality in hereditary myopathy with lactic acidosis.
Sanaker PS; Toompuu M; McClorey G; Bindoff LA
Gene; 2012 Feb; 494(2):231-6. PubMed ID: 22155317
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HOTTIP facilitates cell proliferation, invasion, and migration in osteosarcoma by interaction with PTBP1 to promote KHSRP level.
Yao XY; Liu JF; Luo Y; Xu XZ; Bu J
Cell Cycle; 2021 Feb; 20(3):283-297. PubMed ID: 33475442
[TBL] [Abstract][Full Text] [Related]
14. Identification and Characterization of a Minimal Functional Splicing Regulatory Protein, PTBP1.
Ontiveros RJ; Hernandez L; Nguyen H; Hernandez Lopez AL; Shankar A; Kim E; Keppetipola NM
Biochemistry; 2020 Dec; 59(50):4766-4774. PubMed ID: 33284593
[TBL] [Abstract][Full Text] [Related]
15. Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.
He X; Yuan C; Yang J
Oncotarget; 2015 Oct; 6(30):29651-63. PubMed ID: 26336992
[TBL] [Abstract][Full Text] [Related]
16. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.
Kim JH; Jeong K; Li J; Murphy JM; Vukadin L; Stone JK; Richard A; Tran J; Gillespie GY; Flemington EK; Sobol RW; Lim SS; Ahn EE
Nat Commun; 2021 Sep; 12(1):5551. PubMed ID: 34548489
[TBL] [Abstract][Full Text] [Related]
17. NOVA1 directs PTBP1 to hTERT pre-mRNA and promotes telomerase activity in cancer cells.
Sayed ME; Yuan L; Robin JD; Tedone E; Batten K; Dahlson N; Wright WE; Shay JW; Ludlow AT
Oncogene; 2019 Apr; 38(16):2937-2952. PubMed ID: 30568224
[TBL] [Abstract][Full Text] [Related]
18. PTBP1 enhances exon11a skipping in Mena pre-mRNA to promote migration and invasion in lung carcinoma cells.
Li S; Shen L; Huang L; Lei S; Cai X; Breitzig M; Zhang B; Yang A; Ji W; Huang M; Zheng Q; Sun H; Wang F
Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):858-869. PubMed ID: 31075540
[TBL] [Abstract][Full Text] [Related]
19. The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.
Bielli P; Panzeri V; Lattanzio R; Mutascio S; Pieraccioli M; Volpe E; Pagliarulo V; Piantelli M; Giannantoni A; Di Stasi SM; Sette C
Clin Cancer Res; 2018 Nov; 24(21):5422-5432. PubMed ID: 30012566
[No Abstract] [Full Text] [Related]
20. PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis.
Izaguirre DI; Zhu W; Hai T; Cheung HC; Krahe R; Cote GJ
Mol Carcinog; 2012 Nov; 51(11):895-906. PubMed ID: 21976412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
